In a Turkish cohort, PON-1 levels were significantly lower in patients with multiple myeloma compared with the other groups, whereas no significant correlations were found between PON-1 levels and hemoglobin, creatinine, calcium, or albumin. This evidence concerns the gene PON1 and AL amyloidosis.